openPR Logo
Press release

Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market will perform in Upcoming Years based on Bladder Cancer Therapeutics Market Size, Share, Supply Volume and Major Regions!

02-04-2019 02:53 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Bladder Cancer Therapeutics Market

Bladder Cancer Therapeutics Market

As per stats released by the World Cancer Research Fund International, around 430,000 new cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most common cancer. The bladder holds urine before it leaves the body during urination. The disease in which cancerous cells form in the tissues of the bladder is known as bladder cancer.

Download Free PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/239

There are three major types of bladder cancer and are named on the basis of type of cells become cancerous (malignant). These type are as follows –
• Transitional Cell Carcinoma: Transitional cell carcinoma is also called as urothelial carcinoma. It begins in the urothelial cells of the bladder which are located in the lining the bladder. This is the common type of bladder cancer.

• Squamous Cell Carcinoma: This type of cancer initiates in the squamous cells and it develops in the bladder, following prolonged irritation or infection

• Adenocarcinoma: This type of cancer begins in the secretory cells (glandular) that are located in the lining of bladder. This is very rare type of bladder cancer.

According to the study of American Society of Clinical Oncology (ASCO), urothelial carcinoma accounts for around 90%, squamous cell carcinoma accounts 4% and adenocarcinoma accounts 2% of all bladder cancer. The remaining 4% bladder cancer includes other rare type of bladder cancer viz. sarcoma and small cell anaplastic cancer.

There are different types of treatment followed by doctors, which are mostly dependent on the patient’s preference for treatment and also based on type, possible side effects of the treatment and stage of bladder cancer.

Increasing incidence rate, especially in developed regions fueling growth of bladder cancer therapeutics market

As per stats released by the International Agency for Research on Cancer (IARC), 59% of bladder cancer cases are observed in developed countries, with Belgium reporting the highest number of bladder cancer cases.

As per stats released by Cancer Research UK—a charity involved in cancer research and development—here were around 10,100 new cases reported in the U.K. in 2014. Bladder cancer accounts for around 3% of all new cancer cases reported in the U.K. As per a study by the American Society of Clinical Oncology (ASCO), incidence rate of the disease has decreased by around 12% in the U.K. in the recent past.

According a study by Cancer Research Institute, bladder cancer is more prevalent among men than women. Around 77,000 new cases were diagnosed in the U.S. in 2016, leading to 16,000 deaths. Continuous advancements in clinical research resulted into increased survival rate of people suffering from bladder cancer, which is around 77% observed in last few years. As per the stats of American Cancer Society, bladder cancer accounts for 5% of all new cancer cases in the U.S.

Some are the major reasons behind bladder cancer are unhealthy habits. Smoking is a major cause along with that continuous exposure of industrial chemicals, drinking water with high level of arsenic, family history of bladder cancer, and long-term use of urinary catheters are the other causes of bladder cancer. In Africa and Middle East schistosomiasis and infested water are the leading cause of bladder cancer.

For More Information About This Report @ https://www.coherentmarketinsights.com/ongoing-insight/bladder-cancer-therapeutics-market-239

North America holds major share in the global bladder cancer therapeutics market, followed by Europe due to advanced treatments, developed economy, and easy access to advanced healthcare facilities. The market in APAC region will witness high growth rate in the near future, due to increasing per capita income, developing economy, government initiatives on improving healthcare infrastructure, growing FDI in healthcare, and rapidly increasing aging population. As per stats released by the Department of Industrial Policy and Promotion (DIPP), the healthcare sector in India witness FDI worth US$ 4.09 billion between April 2000 and September 2016. Also, medical tourism in the region is a flourishing business, due to easy access to high-quality low-cost treatment option. According to data released by the India Brand Equity Foundation (IBEF)— a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India—the medical tourism industry in India rakes in US$ 3 billion each  year. This creates a highly conducive environment for growth of the bladder cancer therapeutics market in the region.

Conversely, increasing use of generic drugs, high cost of treatment, asymptomatic nature of the disease and fewer pipeline products inhibit growth of the market. As per data released by the American Cancer Society, only one drug received approval from FDA in last three decade.

Global Key Players:

The major companies playing key role in bladder therapeutics market are Sanofi S.A., F. Hoffmann-La Roche AG, Novartis, Pfizer, Eli Lilly and Co., GlaxoSmithKline, Bristol-Myers Squibb, Allergan Inc, AVI Biopharma Inc., and AstraZeneca plc. Some are the major drugs approved by Food and Drug Administration used for the treatment of bladder cancer are Cisplatin, Nivolumab, Thiotepa, Atezolizumab, Doxorubicin Hydrochloride, Opdivo (Nivolumab), Platinol-AQ (Cisplatin), Platinol (Cisplatin), and Tecentriq (Atezolizumab).

Bladder cancer therapeutics market taxonomy:

Global Market by Bladder Cancer Type
• Urothelial Carcinoma
• Squamous Cell Carcinoma
• Adenocarcinoma

Global Market by Treatment Type
• Surgery
◦ Transurethral bladder tumor resection (TURBT)
◦ Cystectomy
◦ Urinary Diversion
• Chemotherapy
◦ Intravesical (local) Chemotherapy
◦ Systemic (whole body) Chemotherapy
• Immunotherapy
◦ Intravesical Therapy
◦ Interferon Therapy
• Radiation Therapy

Global Market by Test Type
• Biopsy
• Cystoscopy
• Urine Cytology
• Urinalysis
• Bladder Ultrasound

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/239

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market will perform in Upcoming Years based on Bladder Cancer Therapeutics Market Size, Share, Supply Volume and Major Regions! here

News-ID: 1557796 • Views: 202

More Releases from Coherent Market Insights

Mechanical Electrical & Plumbing (MEP) Services Market: We’re Entering an Era!
Mechanical Electrical & Plumbing (MEP) Services Market Report is the new addition announced by The Coherent Market Insights, which offers qualitative insights into factors that impact the growth of the global market. It offers a wide-ranging study of the competitive landscape of the market and also considers the share of the of market key players in each region as well as the overall market by estimating their revenue and sales.
Robot Suitcase Market Scrutinized In New Research By 2026
Robot Suitcase Market Report accessible at Coherent Market Insights gives a overview of the Robot Suitcase Market which cover item scope, advertise income, openings, development rate, deals volumes and figures. The report likewise investigates the overall players of the market and is sectioned by region, type and application with conjecture to 2026. Download PDF Brochure Of This Research Report @ http://bit.ly/2tDP7wL This report subtleties the Robot Suitcase Market beginning with an essential
Semantic Knowledge Graphing Market With Top Companies Google, metaphacts GmbH, S …
The Knowledge Graph can be defined as the knowledge base that is used to improve the search engine's output with information gathered from a variety of sources. The knowledge graph represents a collection of interlinked descriptions of entities – events, abstract concepts, situations, and real-world objects. In knowledge graphing, each entity represents part of the description of the entities, which helps to fetch relative information once the keyword is written
Non-profit Software Market With Top Companies Aplos Software, Bitrix, Blackbaud, …
Non-profit software is specially designed to help non-profit organizations (NGOs) manage various activities of the organization. Non-profit software is equipped with capabilities such as volunteer management, marketing communication, donor management, fund management and fundraising, which helps the non-profit organization to manage funds and volunteers in an effective way, which increases the working efficiency of the organization. 𝑻𝒉𝒆 𝒎𝒂𝒊𝒏 𝒌𝒆𝒚 𝒑𝒍𝒂𝒚𝒆𝒓𝒔 𝒊𝒏 𝒕𝒉𝒆 𝒊𝒏𝒅𝒖𝒔𝒕𝒓𝒚 𝒂𝒓𝒆- Aplos Software, LLC, Bitrix, Inc, Blackbaud, Inc,

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and